4th Nov 2025 07:00
| ||||||||
Condensed Separate Interim Statement of Financial Position as at September 30, 2025 | ||||||||
Notes | Sep. 30, 2025 |
| Dec. 31, 2024 | |||||
|
|
| ||||||
Assets |
| |||||||
Cash and balances at the central bank | 10 | 20,916,631 |
| 136,165,920 | ||||
Due from banks | 11 | 228,152,325 |
| 270,089,441 | ||||
Loans and advances to banks, net | 13 | 26,914,884 |
| 9,555,410 | ||||
Loans and advances to customers, net | 14 | 452,110,898 |
| 340,955,698 | ||||
Derivative financial instruments | 1,222,908 |
| 819,711 | |||||
Financial investments |
|
|
| |||||
- Financial Assets at Fair Value through P&L | 15 | 2,203,869 |
| - | ||||
- Financial Assets at Fair Value through OCI | 15 | 329,796,707 |
| 233,029,903 | ||||
- Financial Assets at Amortized cost | 15 | 228,915,634 |
| 167,276,956 | ||||
Investments in subsidiaries and associates | 16 | 1,255,421 |
| 871,525 | ||||
Non-current assets held for sale | 30 | 159,828 |
| 159,828 | ||||
Other assets | 17 | 49,915,056 |
| 44,175,232 | ||||
Deferred tax assets | 2,457,493 |
| 2,337,304 | |||||
Property and equipment | 18 | 5,470,642 | 3,881,620 | |||||
Total assets |
| 1,349,492,296 |
| 1,209,318,548 | ||||
| Liabilities and equity |
|
|
| ||||
Liabilities |
|
|
| |||||
Due to banks | 19 | 7,043,881 |
| 2,317,715 | ||||
Due to customers | 20 | 1,043,204,762 |
| 967,895,387 | ||||
Derivative financial instruments | 223,670 |
| 100,571 | |||||
Current income tax liabilities | 15,857,818 |
| 18,327,968 | |||||
Other liabilities | 21 | 26,802,780 |
| 21,347,499 | ||||
Issued debt instruments | 22 | 4,779,461 |
| 5,067,781 | ||||
Other loans | 30,249,278 |
| 23,962,389 | |||||
Other provisions | 23 | 14,478,190 | 18,613,060 | |||||
Total liabilities |
| 1,142,639,840 | 1,057,632,370 | |||||
| Equity |
|
|
| ||||
Issued and paid capital | 30,708,510 |
| 30,431,580 | |||||
Reserves | 105,209,974 |
| 63,125,912 | |||||
Reserve for employee stock ownership plan (ESOP) | 2,071,247 |
| 1,868,235 | |||||
Retained earnings* |
| 68,862,725 | 56,260,451 | |||||
Total equity and net profit for the period / year |
| 206,852,456 | 151,686,178 | |||||
| Total liabilities and equity |
| 1,349,492,296 | 1,209,318,548 | ||||
| ||||||||
The accompanying notes are an integral part of these financial statements. |
| |||||||
(Review report attached) |
| |||||||
* | Including net profit for the period |
| ||||||
Condensed Separate Interim Income Statement for the period ended September 30, 2025 | ||||||
|
| Last 9 Months |
| Last 9 Months | ||
| Notes |
| Sep. 30, 2025 |
| Sep. 30, 2024 | |
|
|
|
| |||
|
|
| ||||
Interest and similar income |
| 157,761,416 |
| 130,537,149 | ||
Interest and similar expense |
| (79,403,286) | (65,010,779) | |||
Net interest income |
|
| 78,358,130 | 65,526,370 | ||
|
|
|
| |||
Fee and commission income |
| 11,565,784 |
| 9,257,495 | ||
Fee and commission expense |
| (5,224,939) | (4,048,928) | |||
Net fee and commission income |
|
| 6,340,845 | 5,208,567 | ||
|
|
|
| |||
Dividend income |
| 125,185 |
| 100,858 | ||
Net trading income | 6 |
| 1,276,502 |
| 18,177,630 | |
Profits (Losses) on financial investments | 15.1 |
| 598,228 |
| 377,992 | |
Administrative expenses |
| (11,880,346) |
| (8,795,429) | ||
Other operating income (expenses) | 7 |
| 687,384 |
| (17,980,232) | |
Impairment release (charges) for credit losses | 9 | 7,976,997 | (3,741,208) | |||
Profit before income tax |
| 83,482,925 | 58,874,548 | |||
|
|
|
| |||
Income tax expense | 27 |
| (21,867,730) |
| (16,964,163) | |
Deferred tax assets (Liabilities) | 27 |
| 592,311 | 646,991 | ||
Net profit for the period |
|
| 62,207,506 |
| 42,557,376 | |
|
|
| ||||
Earnings per share | 8 |
|
| |||
Basic | 18.54 |
| 12.50 | |||
Diluted | 18.36 |
| 12.38 | |||
|
|
| ||||
Condensed Separate Interim Statement of Comprehensive Income for the period ended September 30, 2025 |
| |||||||
| Last 9 Months |
| Last 9 Months |
| ||||
| Sep. 30, 2025 |
| Sep. 30, 2024 |
| ||||
|
|
| ||||||
|
|
| ||||||
Net profit for the period |
|
| 62,207,506 | 42,557,376 |
| |||
|
|
| ||||||
Transferred to RE from financial assets at fair value through OCI |
| 3,586 |
| (370,224) | ||||
Net change on financial assets at fair value through comprehensive income after tax |
| 6,805,836 |
| 8,284,110 | ||||
Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income |
|
| (399,884) | 624,524 | ||||
Total comprehensive income for the period |
|
| 68,617,044 |
| 51,095,786 |
| ||
Condensed Separate Interim Cash Flows for the period ended September 30, 2025 | ||||
| ||||
Notes | Sep. 30, 2025 |
| Sep. 30, 2024 | |
|
|
| ||
Cash flow from operating activities |
|
| ||
Profit before income tax |
| 83,482,925 |
| 58,874,548 |
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
| |
Fixed assets depreciation | 18 | 1,244,370 | 763,079 | |
Impairment release/charge for credit losses (Loans and advances to customers and banks) | 9 | (7,980,073) | 4,226,051 | |
Net charged/released for other provisions | 23 | (4,080,370) | 429,182 | |
Impairment release/charge for credit losses (due from banks) | 9 | 151,236 | (5) | |
Impairment release/charge for credit losses (financial investments) | 9 | (148,160) | (484,838) | |
Impairment release/charge for other assets | - | (11,956) | ||
Exchange revaluation differences for financial assets at fair value through OCI and AC | 4,669,694 | (18,536,183) | ||
Revaluation differences impairment charge for Financial Assets at Fair value through OCI | (225,004) | 1,199,896 | ||
Revaluation differences impairment charge for Financial Assets at Amortized cost | (16,709) | 107,207 | ||
Revaluation differences impairment charge for due from banks | (7,813) | 107 | ||
Net utilized/recovered for other provisions | 23 | (2,039) | (9,196) | |
Exchange revaluation differences of other provisions | 23 | (52,461) | 3,963,023 | |
Profits/losses from selling property and equipment | (8,006) | (2,254) | ||
Profits/losses from selling financial investments at fair value through OCI | 15.1 | (416,668) | (377,992) | |
Profits/losses from selling investments in associates | 15.1 | (181,560) | - | |
Share based payments |
| 990,324 |
| 804,345 |
Operating profits before changes in operating assets and liabilities |
| 77,419,686 |
| 50,945,014 |
|
|
| ||
Net decrease / increase in assets and liabilities |
|
|
| |
Due from banks | 158,353,929 | (24,748,544) | ||
Financial assets at fair value through P&L | (2,203,869) | (2,066,889) | ||
Derivative financial instruments | (306,569) | (229,127) | ||
Loans and advances to banks and customers | (120,567,170) | (74,803,105) | ||
Other assets | (2,706,703) | (14,036,648) | ||
Due to banks | 19 | 4,726,166 | (8,606,431) | |
Due to customers | 20 | 75,309,375 | 221,382,197 | |
Current income tax obligations paid | (6,009,912) | (2,694,657) | ||
Other liabilities |
| (12,872,687) | (6,305,033) | |
Net cash generated from (used in) operating activities |
| 171,142,246 |
| 138,836,777 |
|
|
| ||
Cash flow from investing activities |
|
|
| |
Proceeds from sale of investments in associates | 339,920 | 11,956 | ||
Payments for investment in subsidiaries | (542,256) | (200,000) | ||
Payments for purchases of property, equipment and branches construction | (5,833,944) | (2,284,236) | ||
Proceeds from selling property and equipment | 7 | 8,006 | 2,254 | |
Proceeds from redemption of financial assets at amortized cost | 21,249,023 | 1,093,724 | ||
Payments for purchases of financial assets at amortized cost | (83,115,289) | (105,723,312) | ||
Payments for purchases of financial assets at fair value through OCI | (192,334,673) | (21,646,713) | ||
Proceeds from selling financial assets at fair value through OCI | 98,063,752 | 67,015,091 | ||
Net cash generated from (used in) investing activities |
| (162,165,461) | (61,731,236) | |
| ||||
Condensed Separate Interim Cash Flows for the period ended September 30, 2025 (Cont.) | ||||
| ||||
Sep. 30, 2025 |
| Sep. 30, 2024 | ||
|
|
| ||
Cash flow from financing activities |
|
|
| |
Other loans | 6,286,889 | 7,840,786 | ||
Dividends | (14,714,434) | (5,078,792) | ||
Issued debt instruments | (288,320) | 1,738,393 | ||
Capital increase | 276,930 | 236,570 | ||
Net cash generated from (used in) financing activities | (8,438,935) | 4,736,957 | ||
|
|
| ||
Net (decrease) increase in cash and cash equivalent during the period | 537,850 | 81,842,498 | ||
Beginning balance of cash and cash equivalent | 227,028,744 | 233,912,193 | ||
Cash and cash equivalent at the end of the period |
| 227,566,594 |
| 315,754,691 |
|
|
| ||
Cash and cash equivalent comprise: |
|
|
| |
Cash and balances at the central bank | 10 | 20,916,631 |
| 94,285,689 |
Due from banks | 228,295,965 |
| 304,041,410 | |
Treasury bills and other governmental notes | 12 | 140,546,840 | 82,174,775 | |
Obligatory reserve balance with CBE | (2,725,245) |
| (76,128,521) | |
Due from banks with maturity more than three months | (19,202,757) | (17,846,556) | ||
Treasury bills and other governmental notes with maturity more than three months |
| (140,264,840) | (70,772,106) | |
Total cash and cash equivalent |
| 227,566,594 |
| 315,754,691 |
Condensed Separate Interim statement of changes in shareholders' equity | |||||||||||
| Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Total |
Sep. 30, 2024 |
| ||||||||||
Beginning Balance at 1 January 2024 | 30,195,010 | 4,770,354 | 39,840,707 | 1,549,445 | - | 21,155 | (16,808,265) | 15,230 | 29,230,360 | 1,486,010 | 90,300,006 |
Capital increase | 236,570 | - | - | - | - | - | - | - | - | - | 236,570 |
Transferred to reserves | - | 1,438,320 | 22,582,085 | - | - | 1,663 | - | - | (23,398,943) | (623,125) | - |
Dividend paid | - | - | - | - | - | - | - | - | (5,366,429) | - | (5,366,429) |
Net profit for the period | - | - | - | - | - | - | - | - | 42,557,376 | - | 42,557,376 |
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | (370,224) | - | 370,224 | - | - |
Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | 8,284,110 | - | - | - | 8,284,110 |
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | 2,694 | (2,694) | - | - |
Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | 624,524 | - | - | - | 624,524 |
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 804,345 | 804,345 |
Balance at 30 September 2024 | 30,431,580 | 6,208,674 | 62,422,792 | 1,549,445 | - | 22,818 | (8,269,855) | 17,924 | 43,389,894 | 1,667,230 | 137,440,502 |
| |||||||||||
| Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Total |
Sep. 30, 2025 |
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance at 1 January 2025 | 30,431,580 | 6,208,674 | 62,422,792 | 1,549,445 | - | 22,818 | (7,095,741) | 17,924 | 56,260,451 | 1,868,235 | 151,686,178 |
Capital increase | 276,930 | - | - | - | - | - | - | - | - | - | 276,930 |
Transferred to reserves | - | 2,771,284 | 19,758,610 | - | - | 2,246 | - | - | (21,744,828) | (787,312) | - |
Dividends paid | - | - | - | - | - | - | - | - | (14,714,434) | - | (14,714,434) |
Net profit for the period | - | - | - | - | - | - | - | - | 62,207,506 | - | 62,207,506 |
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | 3,586 | - | (3,586) | - | - |
Transferred from net profit to special reserve | - | - | - | - | 13,145,012 | - | - | - | (13,145,012) | - | - |
Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | 6,805,836 | - | - | - | 6,805,836 |
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | (2,628) | 2,628 | - | - |
Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | (399,884) | - | - | - | (399,884) |
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 990,324 | 990,324 |
Balance at 30 September 2025 | 30,708,510 | 8,979,958 | 82,181,402 | 1,549,445 | 13,145,012 | 25,064 | (686,203) | 15,296 | 68,862,725 | 2,071,247 | 206,852,456 |
| |||||||||||
Related Shares:
Com.int.bk.regs